Live feed
Filing
SCHEDULE 13D
SCHEDULE 13D0002072045-25-000002·Malone Wealth Ventures LLC
Schedule 13D ownership disclosure
QUANTUM BIOPHARMA LTD
Common Stock · CUSIP: 74764Y205
Event date: 2025-06-12
- Filing-level shares
- 496,062.00
- Percent of class
- 14.6%
- Malone Wealth Ventures LLCReported CIK 0002072045
Shares: 496,062.00 · Class: 14.6%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0002072045-25-000002
- Form type
- SCHEDULE 13D
- Filer
- Malone Wealth Ventures LLC
- CIK
- CIK 2072045
- Filed
- Jun 12, 2025
- Reporting period
- Jun 12, 2025
- Description
- Schedule 13D beneficial ownership